Literature DB >> 12913724

A prospective study of time and number of ejaculations to azoospermia after vasectomy by ligation and excision.

Mark A Barone1, Hanif Nazerali, Manuel Cortes, Mario Chen-Mok, Amy E Pollack, David Sokal.   

Abstract

PURPOSE: We obtained detailed information on the time and number of ejaculations to azoospermia after vasectomy by ligation and excision.
MATERIALS AND METHODS: Men seeking vasectomy at 3 public clinics in Mexico City were invited to participate in this prospective noncomparative study. Vasectomy was performed using the no-scalpel technique. The vas was occluded using 2 silk sutures and the segment of vas between the ligatures was excised. Men were followed biweekly up to 24 weeks after vasectomy or until azoospermia was confirmed. Semen was examined at each visit for sperm concentration and motility. The main outcome measure was azoospermia in uncentrifuged semen samples.
RESULTS: The life table rate for time to azoospermia was 81.5/100 men (95% CI 76.2 to 86.9) by the end of the study. Cumulative Kaplan-Meier event probability attained a maximum of 79.5/100 men (95% CI 73.7 to 85.2) at 70 ejaculations. Only 60/100 and 27.9/100 men were azoospermic by 12 weeks and 20 ejaculations, respectively. These end points are the commonly recommended waiting periods when semen analysis is unavailable. Of the 217 men 36 (16.6%) did not achieve azoospermia by 24 weeks, of whom 25 (11.5% of all participants) were considered to have vasectomy failure.
CONCLUSIONS: Our results suggest that it is not possible to develop guidelines for clearance based only on the time or number of ejaculations when ligation and excision are performed. In addition, of the methods for vas occlusion during vasectomy ligation and excision may not provide the best success rates.

Entities:  

Mesh:

Year:  2003        PMID: 12913724     DOI: 10.1097/01.ju.0000075505.08215.28

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Vasectomy update 2010.

Authors:  Armand Zini
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

Review 2.  Recent developments in vasectomy.

Authors:  Kerry Wright Aradhya; Kim Best; David C Sokal
Journal:  BMJ       Date:  2005-02-05

3.  CUA guideline: Vasectomy.

Authors:  Armand Zini; John Grantmyre; Peter Chan
Journal:  Can Urol Assoc J       Date:  2016-08-16       Impact factor: 1.862

4.  [Vasectomy : Current information].

Authors:  Thomas Kreutzig-Langenfeld; Ekaterina Lellig; Peter Hinz; Fabian Zilg
Journal:  Urologe A       Date:  2021-03-18       Impact factor: 0.639

5.  UPDATE - 2022 Canadian Urological Association best practice report: Vasectomy.

Authors:  Armand Zini; John Grantmyre; Victor Chow; Peter Chan
Journal:  Can Urol Assoc J       Date:  2022-05       Impact factor: 2.052

6.  Sterilization in the United States.

Authors:  Deborah Bartz; James A Greenberg
Journal:  Rev Obstet Gynecol       Date:  2008

7.  Impact of the 2012 American Urological Association vasectomy guidelines on post-vasectomy outcomes.

Authors:  Robert M Coward; Niraj G Badhiwala; Jason R Kovac; Ryan P Smith; Dolores J Lamb; Larry I Lipshultz
Journal:  J Urol       Date:  2013-08-02       Impact factor: 7.450

8.  Clinical and consumer trial performance of a sensitive immunodiagnostic home test that qualitatively detects low concentrations of sperm following vasectomy.

Authors:  Kenneth L Klotz; Michael A Coppola; Michel Labrecque; Victor M Brugh; Kim Ramsey; Kyung-ah Kim; Mark R Conaway; Stuart S Howards; Charles J Flickinger; John C Herr
Journal:  J Urol       Date:  2008-10-19       Impact factor: 7.450

9.  Frequency and patterns of early recanalization after vasectomy.

Authors:  Michel Labrecque; Melissa Hays; Mario Chen-Mok; Mark A Barone; David Sokal
Journal:  BMC Urol       Date:  2006-09-19       Impact factor: 2.264

10.  Vasectomy by ligation and excision, with or without fascial interposition: a randomized controlled trial [ISRCTN77781689].

Authors:  David Sokal; Belinda Irsula; Melissa Hays; Mario Chen-Mok; Mark A Barone
Journal:  BMC Med       Date:  2004-03-31       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.